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ABSTRACT 
Corneal pseudoguttata (PG), also known as pseudoguttae or secondary guttata, is a transient, reversible endothelial edema 
commonly associated with anterior segment pathology. While considered rare, PG presents on slit-lamp examination more 
commonly than originally thought. We have clinically observed PG after refractive surgeries, in association with infectious 
keratitis, and following medication use. PG presents as dark lesions on slit-lamp exam with specular illumination, similar to 
primary corneal guttata. PG is distinct from guttata because PG resolves over time and does not involve Descemet’s 
membrane. Other ocular findings that may be confused with guttata include endothelial blebs (EB) and endothelial 
denudation (ED). EB are possibly a type of PG that present after contact lens use or hypoxia. ED is a distinct entity that is 
characterized by loss of endothelial cells without involvement of Descemet’s membrane. Confocal microscopy may be useful 
in differentiating these four endothelial lesions, with differences in border definition and the presence of hyperreflective 
areas two main distinctions. PG presents as a hyporeflective, elevated shape without clear borders on confocal microscopy. 
PG, EB, and ED can resolve with time without the need for surgical intervention, unlike corneal guttata. Treatment of the 
underlying condition will lead to resolution of both PG and EB. 
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INTRODUCTION
The corneal endothelium is a mono-layer of hexagonal 
cells attached to Descemet’s membrane. This layer is 
vital for maintaining the transparency of the cornea 
through hydration mechanisms involving the 
bicarbonate-ATP dependent pump, and damage to the 
endothelial layer can lead to serious, irreversible changes 
in vision [1]. Certain disorders such as Fuchs’ corneal 
dystrophy can cause dysfunction or death of the 
endothelial cells, leading to a condition known as guttata 
[2]. Guttata, otherwise known as guttae or true guttata, 
are characterized by outpouchings of Descemet’s 
membrane [3, 4]. The cause of Fuchs’ dystrophy has been 
theorized to be due to thickening of Descemet’s 
membrane that causes destruction of endothelial cells 
[2]. In contrast, pseudoguttata (PG), also known as 
“pseudoguttae” or “secondary guttae,” is transient and 
completely reversible areas of endothelial edema 
without Descemet’s involvement [3, 4]. PG may present 
clinically similar to guttata. Similarities between PG and 
guttata can lead to ambiguity in clinical evaluation; 
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however, it is important to differentiate between the two 
since their treatment regimens differ. The purpose of this 
paper is to provide an overview of PG, highlighting the 
differences between guttata, PG, and other PG-like 
ocular findings such as endothelial blebs (EB) and 
endothelial denudation (ED), and to describe the clinical 
evaluation and management of these distinct entities. 
We review the literature covering the clinical course, 
differential diagnosis, etiology, pathology, treatment, 
and diseases associated with PG. 
METHODS 
A literature search on PG was performed using the 
following sources: Pubmed, Google Scholar, Embase, and 
Scopus with keywords “guttata,” “guttae,” 
“pseudoguttata,” “pseudoguttae,” “pseudo guttae,” 
“Hassall-Henle bodies,” “guttaless Fuchs’ Dystrophy,” 
“Fuchs’ Dystrophy without guttata,” “endothelial bleb,” 
“endothelial denudation,” and “secondary guttata.” 
Multiple ophthalmology textbooks were examined, 
looking for those same keywords. There were no 
language restrictions. Publications were drawn between 
the dates of 1900-2019. Of the 139 articles found on PG, 
only 25 articles mentioned the ocular finding and were 
accessible online. Of these, 4 were case reports, 0 were 
review articles, and 6 articles overlapped with 
descriptions of the same information. A total of 19 
articles provided unique information, and of these, only 
14 mentioned the word “pseudoguttata” or other 
derivations of the word, with the other five articles 
reporting EB. Of the 14 articles mentioning 
“pseudoguttata,” eight articles examined PG in 
association with different conditions, and two articles 
examined the correlation between PG and ocular 
biometric data such as endothelial cell count and 
intraocular pressure (IOP). The majority of articles were 
case reports focusing on the characteristics of PG. In the 
publications found in this literature review, there were 
collectively 322 documented cases of PG. 
Medical records from Dr. Moshirfar’s clinical practices at 
the University of Utah and Hoopes Vision from 1996-
2019 were examined to find ophthalmic surgical 
procedures, diseases, medications, or other conditions 
that were noted with slit-lamp findings of PG, transient 
guttata, or secondary guttata. These charts were 
analyzed to classify associations with PG based on 
disease, surgery, and medication toxicity. 
Terminology 
Corneal guttata was first mentioned in 1921 by Vogt with 
the word “guttata” when describing the appearance of 
Fuchs’ dystrophy under a slit lamp [3, 5]. “Guttata” is an 
adjective that means full of drops [6]. In recent years, the 
Latin word “gutta,” a singular noun for the word 
teardrop, has been replacing the word “guttata” in the 
literature [6, 7]. Although neither word is incorrect, in 
clinical practice, “guttae” is used to describe the physical 
findings while “guttata” refers to the condition of having 
guttae [6, 7]. Figure 1 highlights these differences. Before 
1921, the term was used throughout literature to 
describe drop-like appearances on the body, including a 
type of skin lesion seen in scleroderma [8]. PG, as so 
named due to its resemblance to guttata, was first 
mentioned in 1959 by Wolter and Larson to describe 
outgrowths of Descemet’s membrane in a patient with 
interstitial keratitis under the name “secondary guttae” 
[3, 9]. It is now understood that PG is not associated with 
Descemet’s membrane. Past articles dating back to 1977 
have also referred to a PG-like condition using the words 
“endothelial blebs,” [10] which were originally thought to 
be associated with the same causes as PG [11-13]. From 
a semantic point of view, the correct term to describe 
the raised lesions on slit-lamp exam is “pseudoguttae.” 
However, many people use the word interchangeably 
with “pseudoguttata,” which refers to the condition or 
state of having endothelial cellular edema. Although we 
use the term “pseudoguttata” in this paper, we hope to 
clarify this for our readers. 
 
Gutta  [14]/ ˈɡʌtə /   Noun 
gutta (singular; gtt*) guttae (plural; gtts*) 
Drop, as in a teardrop or a small, rounded amount of liquid 
Latin 
Guttate [15]/ ˈgʌt eɪt /   Adjective 
guttate, guttata 
Full of drops 
Latin 
Figure 1: Distinctions of the Various Forms of the Word “gutta.” These 
Rules also apply to Words such as “pseudogutta” and “secondary 
gutta.” *Abbreviations for gutta commonly seen to Denote Eyedrops 
 
It is important to define terminology before proceeding. 
PG is a condition involving reversible areas of endothelial 
edema without Descemet’s involvement [3, 4]. Guttata is 
characterized by outpouchings of Descemet’s membrane. 
EB are possibly a type of PG that present after contact 
lens use with endothelial cell edema, quickly resolving 
after removal of the causative agent [12, 13]. Due to this 
similarity, this article refers to EB strictly in association 
with contact lens use [16]. ED is loss of endothelial cells 
without involvement of Descemet’s membrane [17]. 
Etiology 
PG is caused by intra- and inter-cellular edema [3, 4]. 
Most sources report PG as a condition triggered by 
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endothelial cell injuries, iritis, corneal inflammation, or 
alterations in endothelial pH, with the most common 
cause being inflammation-associated uveitis [3, 18, 19]. 
An example of corneal inflammation is endotheliitis, 
which manifests as corneal edema and PG [20]. 
Endotheliitis can be caused by viral, bacterial, or fungal 
agents [20]. Specifically, cytomegalovirus and herpes 
simplex virus keratitis have both been linked to the 
condition [17, 21, 22]. Hypoxia causing lactate buildup in 
the aqueous humor also appears to be related to PG; five 
hours after an ultramarathon, a patient presented with 
guttata that resolved 48 hours later, leading us to classify 
the finding as PG. The mechanism was reported as 
oxidative stress leading to the disruption of corneal 
endothelium regulation [23]. Past studies suggested that 
high IOP can also result in endothelial edema and PG [3], 
but recent findings in animal studies suggest that PG can 
be caused by low IOP as well [24]. Topical Ripasudil, a 
Rho-kinase inhibitor, has been associated with 
morphological changes resembling PG formation, 
possibly due to increased cell migration and 
polymegathism [25, 26].  
From 1996-2019, we have seen PG associated with many 
medical conditions and surgeries in our clinic. Both 
excimer and femtosecond assisted procedures (i.e. Laser-
assisted in-situ keratomileusis [LASIK] and 
photorefractive keratectomy [PRK]) and manual incision 
surgeries (i.e. Radial keratotomy [RK] and 
phacoemulsification) produce PG in the post-operative 
period. PG has also presented during medical treatments 
such as intravitreal injections, antimicrobial agents, and 
Mitomycin-C application. For further details about these 
associations, refer to Table 1. We surmise that PG 
appears because of transient focal or localized 
endothelial injury, such as what occurs after surgeries 
and in ocular diseases. Such injury leads to disruption of 
the membrane pumps in the endothelial cells; however, 
this disruption is not severe enough to cause permanent 
dysfunction. 
Epidemiology 
In the last eighty years, there has only been one published 
article on the incidence of PG, reported as 1.1% in one 
clinical ophthalmology practice. In that same practice, the 
mean age of patients presenting with PG was 41.1 years; 
however, this may be more indicative of the average age of 
patients who undergo ophthalmic procedures [18]. In 
general, it is difficult to conclude a precise measure of 
incidence or demographic patterns associated with PG due 
to its short-lived nature [3]. This is perhaps why there is a 
shortage of literature reporting PG incidence. 
 
Genetics 
PG is associated with only one specific genetic disorder: 
keratoendotheliitis fugax hereditaria, which is an 
autosomal dominant, autoinflammatory disorder of the 
cornea resulting in corneal opacities and unilateral 
attacks of pain, injection, and photophobia [27]. 
Recently, mutations in the leucine-rich repeat (NLR) 
family, pyrin domain-containing 3 (NLRP3) gene have 
been implicated in the cause of keratoendotheliitis fugax 
hereditaria in a Finnish population. This disease is 
unrecorded in other ethnicities; however, more genetic 
links to PG may be uncovered with future investigations 
[27].  
 
 
Table 1: Common Conditions, Surgical Procedures, and Medication 
Toxicities presenting with Pseudoguttata in Dr. Moshirfar’s Clinical 
Practices at the University of Utah and Hoopes Vision 
Conditions and Surgeries Associated with Pseudoguttata 
Infectious keratitis/iritis/endotheliitis 
Viral (herpes simplex virus, varicella zoster virus, Epstein-Barr Virus, 
cytomegalovirus) 
Bacterial 
Fungal 
Parasitic 
Post-surgical inflammation 
Excimer laser (photorefractive keratectomy, laser-assisted in-situ 
keratomileusis) 
Femtosecond laser (laser-assisted in-situ keratomileusis, small-incision 
lenticule extraction) 
Radial Keratotomy (RK) 
Superficial Keratectomy 
YAG Laser (iridotomy, capsulotomy) 
Pterygium excision 
Phacoemulsification 
Intraocular lens (IOL) explantation/implantation 
Ultraviolet (UV) Collagen Crosslinking 
Glaucoma laser surgery 
Glaucoma trabeculectomy 
Phakic IOL implantation 
Conductive keratoplasty 
Laser thermal keratoplasty 
Deep anterior lamellar keratoplasty 
Vitreoretinal procedure with and without gas/fluid exchange 
Medication toxicity 
Fortified vancomycin 
Benzalkonium chloride (BAK) toxicity 
Toxic anterior segment syndrome (TASS) related injury 
Miostat 
Mitomycin C 
Intravitreal injection (anti-vascular endothelial growth factor, antibiotics) 
Anti-glaucoma medications, Rho-kinase inhibitors, angiotensin-converting-
enzyme inhibitors 
Chemical (Palytoxin) 
Other conditions 
Endophthalmitis 
Uncontrolled open-angle glaucoma 
Angle-closure glaucoma 
Blunt injury: airbag, human fist, head trauma 
Thermal and chemical injury 
Contact lens keratopathy 
UV and infrared (IR) injury: welding, skiing, sunbathing, sunburn 
Lactate buildup (ultramarathon) 
Hypoxia 
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Corneal guttata, on the other hand, is associated with 
Fuchs’ endothelial cell dystrophy (FECD), and it is 
characterized mostly by autosomal dominant inheritance 
and mutations in the COL8A2 gene [2-4, 28, 29]. Corneal 
guttata can also occur in isolation in an autosomal 
dominant pattern, without any association to Fuchs’ 
dystrophy [3, 4, 28]. 
Diagnosis 
Clinical Evaluation 
It is difficult to clinically differentiate between guttata 
and PG as traditionally, PG is a diagnosis of exclusion. 
Patients with PG may present with a previously 
documented guttata-like appearance that resolved over 
time. Patients with PG are typically asymptomatic [3, 18]. 
PG appears similar to guttata on slit lamp with specular 
illumination, showing dark lesions and outgrowths on the 
corneal endothelium [3, 18]. However, endothelial cells 
surrounding PG are mostly unaffected, retaining a 
regular mosaic pattern (Fig. 2) [3, 30]. Guttata presents 
under the slit lamp as mushroom-like excrescences or 
projections of Descemet’s membrane considered to be a 
sign of aging or damaged endothelial cells [30]. Guttata 
may present with corneal edema on slit lamp secondary 
to endothelial cell loss in patients with Fuchs’ dystrophy 
[2]. Interestingly, one article mentioned a slight increase 
in central corneal thickness with the presence of PG, 
although the clinical significance of this is unknown as 
slit-lamp exam does not normally show corneal edema 
with PG [4]. On slit lamp, EB may appear similar to PG, 
and ED is undetectable [17]. 
 
Figure 2: Image Showing a Cross-Section of the Corneal Layers 
Differentiating Endothelial Cells in Corneal Guttata, Pseudoguttata, 
and Endothelial Denudation. The Normal Mosaic Pattern of 
Endothelial Cells in Pseudoguttata Contrast with the Destruction of 
the Surrounding Endothelial Cells in corneal Guttata. Corneal Guttata 
Presents with Excrescences of Descemet’s Membrane while 
Descemet’s Membrane is Left Intact without any Irregularities in 
Endothelial Denudation and Pseudoguttata. 
Histopathologic Evaluation 
Based on the current literature, histopathologic evaluation 
may help differentiate between PG and guttata. Histological 
staining with nitroblue tetrazolium stain is negative in 
endothelial cells with damaged nuclei, such as those seen in 
corneal guttata, and would exhibit an abnormal endothelial 
pattern [30]. The presence of PG does not impact 
endothelial cell density as neighboring cells are unaffected 
by the edema [31]. 
Other sources of PG, such as infection, can result in a 
cellular reaction and polymorphonuclear infiltration of the 
anterior stroma and a guttata-like appearance [3]. This 
infiltration has also been shown with herpes simplex virus 
keratitis, but it is unclear whether the inflammatory 
infiltrate was a result of the PG or the keratitis [17]. 
Confocal, specular, and light microscopy can be used to 
supplement history and slit-lamp exam findings of PG, 
guttata, EB, and ED. Confocal microscopy specifically may be 
used to differentiate among these four lesions. Table 2 
summarizes the differences among these conditions. 
Confocal Microscopy 
Confocal microscopy shows both PG and guttata as dark, 
elevated shapes without sharp borders [17]. Guttata 
presents with a white dot in its center, unlike PG  [17]. It has 
been theorized that the white spot occurs due to the 
reflection of light from the apex of the edema while the 
dark area results from the sides of the cell reflecting light 
away from the microscope [16]. EB and PG can be 
distinguished on confocal microscopy; EB appear as dark, 
elevated circles with a hyperreflective white dot in their 
center [16, 17]. PG, which is also characterized by cellular 
edema, does not show this hyperreflective spot, suggesting 
that more research is required to explain these findings. In 
contrast to the borderless PG, blebs appear sharp and well-
defined [17]. ED appears as a large, sharply-defined hole 
[17]. 
Specular Microscopy 
Assessment of PG with specular microscopy reveals 
numerous dark holes of different sizes (Fig. 3) [3, 18]. EB and 
ED may appear similar to PG on specular microscopy, also 
presenting as dark lesions. 
Light Microscopy 
Guttata can be distinguished from PG by its characteristic 
outpouching appearance on light microscopy, caused by the 
overlying and surrounding endothelial cells that degenerate 
and deposit increased basement membrane [28, 30]. 
 
Differential Diagnosis 
Guttata commonly affects middle- to older-aged patients 
and is seen mostly in the center of the cornea [28]. 
Peripheral corneal guttata, also known as Hassall-Henle 
bodies, presents mainly in younger patients [3, 28]. Corneal 
guttata may occur more frequently in women, but this 
association remains inconclusive in the current literature 
[18]. 
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Etiology of corneal guttata must also be considered because 
the ambiguity of PG may lead to misreporting of clinical 
findings. Iridocorneal Endothelial Syndrome (ICE), 
Chandler’s syndrome, angle-closure glaucoma, relative 
anterior microphthalmos, Brown-McLean syndrome, 
posterior polymorphous corneal dystrophy (PPMD), and RK 
have been associated with corneal guttata-like changes on 
histopathological examination [32-38]. RK appears to be an 
example of a nonhereditary cause of guttata, which is 
characterized by endothelial degeneration  [38].  
 
Table 2: Differentiation between Gutta, Pseudoguttata, Endothelial Blebs, and Endothelial Denudation Using Confocal and Specular Microscopy. 
 Guttata Pseudoguttata Endothelial blebs Endothelial denudation 
Pathophysiology 
Excrescences of Descemet’s 
membrane that destroy the 
surrounding endothelial cells 
Commonly caused by 
inflammation, infection, or 
uveitis leading to cellular 
edema potentially with 
inflammatory infiltrate 
Commonly associated with an acidic 
change in pH with respect to 
aqueous humor caused by contact 
lens wear and anoxia leading to 
water-filled endothelial edema 
Characterized by the 
absence of endothelial 
cells with retention of 
Descemet’s membrane 
Appearance on 
specular 
microscopy 
Dark spots or lesions Dark spots or lesions Dark spots Dark defects 
Appearance on 
confocal 
microscopy 
Hyporeflective, elevated 
shape without clear borders; 
has a hyperreflective white 
dot in the center 
Hyporeflective, elevated 
shape without clear borders 
Hyporeflective, elevated shape with 
clear borders; has a hyperreflective 
white dot in the center 
Large, sharply defined 
hyporeflective hole 
Confocal 
microscopy 
illustration 
    
We surmise that PG, EB and ED are a spectrum of clinical 
manifestations of transient endothelial cell injury of various 
causes. EB can be seen within ten minutes of insertion of a 
contact lens and increase rapidly in number before partially 
resolving after forty-five minutes [16]. Interestingly, the 
density of blebs has been reported highest in patients of 
Asian ethnicity [16]. They appear due to a stressed corneal 
endothelium, and chronic conditions may lead to a decrease 
in endothelial cell count [13, 16].  
EB were reported following anoxia, with the underlying 
cause attributed to the acidic change in pH [16, 19]. Any 
source of hypoxic stress, such as contact lenses, has also 
been associated with polymegathism [39]. The incidence 
of EB has been theorized to be 100% in contact-lens 
wearers [16]. The acidic change in pH with respect to the 
aqueous humor leads to water-filled vacuoles 
accumulating in endothelial cells, causing cellular edema. 
As Descemet’s membrane provides more resistance than 
the aqueous humor, EB project posteriorly into the 
anterior chamber [11, 16]. Like PG, EB are transient [17, 
40]. As previously mentioned, ED is characterized by loss 
of endothelial cells without any insult to Descemet’s 
membrane. They generally take weeks to heal, and 
endothelial cell loss has reportedly been caused by 
endothelial contusion, glaucoma, and surgeries [17, 41]. 
 
Management and Prognosis 
PG, EB, and ED do not require any surgical intervention. 
There are many clinical incidences where PG has 
presented on slit-lamp exam but resolved without any 
intervention the following day. However, some external 
causes of PG such as inflammation, uveitis, or infection 
will disappear within days after resolution of the 
underlying etiology [3, 30, 31]. For example, PG caused 
by inflammation may require prednisolone, while PG 
caused by bacterial infection may require antibiotics [3]. 
Figure 3: Pictures taken of a Patient who presented with 
Pseudoguttata following Collagen Cross-Linking for Endotheliitis. A: A 
Resolving Epithelial Defect after Collagen Cross-linking. B: Slit-lamp 
exam showing Pseudoguttata as Raised Dots. The Arrows Highlight 
Pseudoguttae. C: Image of Pseudoguttata taken with a Specular 
Microscope showing the Hexagonal Mosaic of the Endothelial Cells 
and the Large, Dark Regions representing these Lesions. 
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PG can appear in a variety of situations, without resultant 
harm or lasting damage [18].  
EB typically resolve within minutes after removal of the 
contact lens. However, some reports have noted 
spontaneous resolution of blebs even with the 
continuous use of contact lenses [18]. ED persists for 
weeks after cessation of the insult but will disappear with 
the migration of reserve endothelial cells, similar to what 
occurs after Descemet’s stripping without endothelial 
keratoplasty (DWEK) [17, 42]. Thus, ED is the result of 
DWEK and can be seen in patients undergoing this 
treatment for early-stage Fuchs’ dystrophy. After DWEK, 
Rho-kinase inhibitors are often used to accelerate the 
rate of endothelial cell migration and can possibly treat 
other forms of ED [42, 43]. 
CONCLUSION 
Understanding PG is important in order to differentiate 
various ocular exam findings. In recent literature, PG has 
been defined as transient endothelial cell edema that 
appears similar to primary corneal guttata on slit-lamp 
examination. With the numerous conditions we have 
seen associated with PG, we argue that PG occurs more 
frequently than previously reported. EB may be a specific 
type of PG associated with contact lens wear. Although 
EB appear differently on confocal microscopy, this may 
be due to edema caused by water-filled vacuoles rather 
than inflammatory infiltrate. Their underlying causes are 
different, but clinicians should manage EB and PG in a 
similar manner. Corneal guttata and ED are defined by 
damage to endothelial cells. However, ED resolves with 
migration of endothelial cells while guttata is 
characterized by more lasting damage. In addition to 
permanent endothelial damage, guttata has 
excrescences of Descemet’s membrane. PG, EB, ED, and 
corneal guttata can be differentiated on confocal 
microscopy. Studies are still reporting new findings and 
associations with PG, and our understanding of these 
clinical manifestations will increase with time. Guttata is 
a disease process, indicative of permanent damage that 
may lead to vision loss. It is important to distinguish PG 
from guttata in order to tailor appropriate treatments. 
Having a better understanding of the two can assist 
physicians in appropriate diagnosis and clinical 
management. 
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